Design, Synthesis, Biological Screening, and Molecular Docking Studies of Piperazine‐Derived Constrained Inhibitors of DPP‐IV for the Treatment of Type 2 Diabetes

Publisher： John Wiley & Sons Inc

E-ISSN： 1747-0285|85|4|439-446

ISSN： 1747-0277

Source： CHEMICAL BIOLOGY & DRUG DESIGN (ELECTRONIC), Vol.85, Iss.4, 2015-04, pp. : 439-446

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Indole Alkaloids as New Leads for the Design and Development of Novel DPP-IV Inhibitors for the Treatment of Diabetes

By  

Current Bioinformatics, Vol. 13, Iss. 2, 2018-03 ,pp. : 157-169

Bentham Science Publishers

Access to resources Recommend Favorite

Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation

By Meduru Harika   Wang Yeng-Tseng   Tsai Jeffrey J. P.   Chen Yu-Ching  

International Journal of Molecular Sciences, Vol. 17, Iss. 6, 2016-06 ,pp. : 920-920

MDPI

Access to resources Recommend Favorite

Synthesis, Biological Evaluation, and Molecular Docking Studies of Xanthone Sulfonamides as ACAT Inhibitors

By  

CHEMICAL BIOLOGY & DRUG DESIGN (ELECTRONIC), Vol. 85, Iss. 3, 2015-03 ,pp. : 394-403

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel 4‐Heteroaryl‐Antipyrines as DPP‐IV Inhibitors

By  

CHEMICAL BIOLOGY & DRUG DESIGN (ELECTRONIC), Vol. 86, Iss. 5, 2015-11 ,pp. : 1292-1303

John Wiley & Sons Inc

Access to resources Recommend Favorite

Design, Synthesis and Molecular Docking Studies of Novel Indole–Pyrimidine Hybrids as Tubulin Polymerization Inhibitors

By  

CHEMICAL BIOLOGY & DRUG DESIGN (ELECTRONIC), Vol. 86, Iss. 6, 2015-12 ,pp. : 1491-1500

John Wiley & Sons Inc

Access to resources Recommend Favorite